Compare Humana Inc (HUM) vs KeyCorp (KEY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs KeyCorp — how do they compare? Humana Inc trades at $453.46 (market cap $46.49B), while KeyCorp trades at $20.1 (market cap $21.45B). The key difference: Humana Inc is far larger — about 2.2× KeyCorp's market cap, and KeyCorp pays the higher dividend (4.08%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and KeyCorp for 66 Days on average.
| HUM | KEY | |
|---|---|---|
Market Cap | $46.49B | $21.45B |
Volume | 2,567,704 | 19,450,846 |
Sector | Health | Financials |
52-Week High | $409.85 | $23.99 |
52-Week Low | $163.67 | $16.78 |
Typical Hold Time | 53 Days | 66 Days |
Enterprise Value | $53.84B | $34.63B |
Dividend Yield | 0.91% | 4.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
KeyCorp (KEY) trades at $19.83, down 1.54% with a bearish technical signal. The stock shows strong fundamentals with a P/E of 11.75, net income margin of 26.72%, and three consecutive quarterly earnings beats. Recent management appointments and a 2026 revenue outlook raise to 8% growth signal operational momentum. However, technical indicators show oversold conditions with RSI at 26.31 and bearish moving average signals.
KEY presents a value opportunity with attractive valuation metrics and consistent earnings performance. The 26% upside to consensus price target of $25.00 and 60.79% analyst buy rating support bullish sentiment. Risks include frozen dividend payments since 2023 and sensitivity to interest rate changes. The bank's aggressive share buyback program and improving net interest income provide catalysts for potential appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →
